Quinn William P. sold 6,545 shares of Bolt Biotherapeutics, Inc. at $3.32 for −$21.7k on Sep 17, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
President, CEO and CFO
President, CEO and CFO
Filed Sep 21, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$21,718.27Shares × reported price
Shares traded
6,545Common Stock
Price per share
$3.32Reported price. Read footnotes for ranges.
% of reported position traded
15.94%This security and ownership context
Holdings after
34,516Direct
Trade date
Sep 17, 2026Sell
Filed
Sep 21, 2026, 6:03 PM ET4-day reporting delay
Accession
0001193125-26-396890Code S · Transaction 227038
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 41,061 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 16, 2026Sell1,889$3.77−$7,129.09Trade 227037
Sep 18, 2026Sell9,132$3.24−$29,554.80Trade 227039
Jun 5, 2026Buy637$3.88$2,469.01Trade 227036
4 transaction rows in this filing. Joint filers share the same rows.

BOLT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BOLT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −18%1w ago 0%1d ago 0%
Returns since7d −10%30d +7.3%90d180d1y

Footnotes in full

F1: These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c). F2: Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3: Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F4: Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.